Category / Pharmaceuticals & Medicine

Companies
12

Accepting reservations

Yakuru Inc.

Precision supplements, biometrics, and AI performanc...

Companies

Republic Funding Portal · Reg CF

Funded

32 Biosciences

Gut microbiome medicine with an initial market oppor...

Companies

Republic Funding Portal · Reg CF

Funded

SharpMed

Delivering the advanced, cost-effective medical devi...

Companies

Republic Funding Portal · Reg CF

Funded

Accredited only

Aspire BioPharma

Disruptive technology that improves medicine effecti...

Companies

Capital R · Reg D 506(c)

Funded

Aspire BioPharma

Disruptive technology that improves medicine effecti...

Companies

Republic Funding Portal · Reg CF

Funded

iRemedy Healthcare

Solving the pain of today's medical supply chain wit...

Companies

Capital R · Reg A+

Funded

NeXtGen Biologics ™

Patented, FDA-cleared, novel wound-care technology |...

Women Founders

Companies

Republic Funding Portal · Reg CF

Funded

NovaXS Biotech Corp.

Needle-free self-injection technology | Ease of use,...

Companies

Women Founders

Republic Funding Portal · Reg CF

Funded

Recovered Health...

Automating pharmacy logistics and communications

Companies

Veteran Founders

Republic Funding Portal · Reg CF

Funded

CNS Pharma

Breakthrough technologies for central nervous system...

Companies

Social Impact

Republic Funding Portal · Reg CF

Funded

FreshMynd

Breakthrough ADHD supplement for kids backed by 20+ ...

Republic Funding Portal · Reg CF

Funded

RMR Laboratories

Injection-like delivery of cannabis through your ski...

Companies

Veteran Founders

Republic Funding Portal · Reg CF

Events
0

Blog posts
1

Founders

John Climaco, CNS Pharma

John Climaco started CNS Pharmaceuticals in search of a simple goal: to cure glioblastoma and other cancers of the brain and central nervous system. To accomplish this, our team is developing anticancer agents that target cancers of the central nervous sys...

Investor Groups
0

Press
32

Press about Pharmaceuticals & Medicine

Crowdfunding 'could transform cancer treatment worldwide'

Thepharmaletter

Feb 28, 2017

In what is believed to be the first move of its kind ever, healthcare profess...

Press from companies related to Pharmaceuticals & Medicine

Engineered Drug May Directly Fight Glioblastoma Tumors

Cure Today

Berubicin, a new drug being developed for the treatment of glioblastoma, may ...

Breakthrough Cancer Technology To Be Funded By The Crowd ...

markets.businessinsider.com

HOUSTON, March 20, 2018 /PRNewswire/ -- In a step toward democratizing the fi...

Berubicin Breaches Blood-Brain Barrier to Attack Brain Tu...

Oncology Nursing News

Berubicin, a powerful anthracycline, may be able to access and treat glioblas...

View all 31 articles

Followers
5977

and 5953 more

Categories

›

Pharmaceuticals & Medicine

Refer a startup, get $2,500

Invest in the app

This site (the "Site") is owned and maintained by OpenDeal Inc., which is not a registered broker-dealer. OpenDeal Inc. does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this Site is the responsibility of, the applicable issuer of such securities. The intermediary facilitating the offering will be identified in such offering’s documentation.

All related securities activity is conducted by OpenDeal Broker LLC a registered broker-dealer, Member of FINRA and SiPC, an affiliate of OpenDeal Inc. and OpenDeal Portal LLC, located at 149 5th Avenue, 10th Floor, New York, NY 10010. Please check our background on FINRA’s BrokerCheck.

Certain pages discussing the mechanics and providing educational materials regarding regulation crowdfunding offerings may refer to OpenDeal Broker LLC and OpenDeal Portal LLC collectively as “Republic”, solely for explanatory purposes.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC make investment recommendations and no communication, through this Site, or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Investment opportunities posted on this Site are private placements of securities that are not publicly traded, involve a high degree of risk, may lose value including the total loss of invested capital, are subject to holding period requirements and are intended for investors who do not need a liquid investment. Past performance is not indicative of future results. Investors must be able to afford the loss of their entire investment. Only qualified investors, who understand the risks of early-stage investment and who meet the Republic's investment criteria may invest. Investors may be restricted to only Accredited Investors or non-U.S. persons, to invest in offerings hosted by OpenDeal Broker. Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC, nor any of their officers, directors, agents and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information on this Site or the use of information on this site. Offers to sell securities can only be made through official offering documents that contain important information about the investment and the issuers, including risks. Investors should carefully read the offering documents. Investors should conduct their own due diligence and are encouraged to consult with their tax, legal and financial advisors.

By accessing the Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy. Please also see OpenDeal Broker’s Business Continuity Plan and Additional Risk Disclosures. All issuers offering securities under regulation crowdfunding as hosted by OpenDeal Portal LLC are listed on the All Companies Page. The inclusion or exclusion of an issuer on the Platform Page and/or Republic’s Homepage, which includes offerings conducted under regulation crowdfunding as well as other exemptions from registration, is not based upon any endorsement or recommendation by OpenDeal Inc, OpenDeal Portal LLC, or OpenDeal Broker LLC, nor any of their affiliates, officers, directors, agents, and employees. Rather, issuers of securities may, in their sole discretion, opt-out of being listed on the Platform Page and Homepage.

Investors should verify any issuer information they consider important before making an investment.

Investments in private companies are particularly risky and may result in total loss of invested capital. Past performance of a security or a company does not guarantee future results or returns. Only investors who understand the risks of early stage investment and who meet the Republic's investment criteria may invest.

Neither OpenDeal Inc., OpenDeal Portal LLC nor OpenDeal Broker LLC verify information provided by companies on this Site and makes no assurance as to the completeness or accuracy of any such information. Additional information about companies fundraising on the Site can be found by searching the EDGAR database, or the offering documentation located on the Site when the offering does not require an EDGAR filing.

To help the government fight the funding of terrorism and money laundering activities, Federal law requires all financial institutions to obtain, verify, and record information that identifies each person who opens an account. Therefore, when you use the Services we will ask for your name, address, date of birth, and other information that will allow us to identify you. We may also ask to see your driver's license, passport or other identifying documents.

Republic and its affiliates are not and do not operate or act as a bank. Certain banking services are provided by BitGo Trust Company, a South Dakota-chartered trust company and registered money services business. BitGo Trust Company is not an FDIC member. Digital (crypto) assets and investment products are not insured by the FDIC, may lose value, and are not deposits or other obligations of BitGo Trust Company and are not guaranteed by BitGo Trust Company. Terms and conditions apply.

Invest in startups using your credit card

Made in SF/NYC

Category / Pharmaceuticals & Medicine

Companies 12

Yakuru Inc.

32 Biosciences

SharpMed

Aspire BioPharma

Aspire BioPharma

iRemedy Healthcare

NeXtGen Biologics ™

NovaXS Biotech Corp.

Recovered Health...

CNS Pharma

FreshMynd

RMR Laboratories

Events 0

Blog posts 1

Founders

John Climaco, CNS Pharma

Investor Groups 0

Press 32

Press about Pharmaceuticals & Medicine

Crowdfunding 'could transform cancer treatment worldwide'

Press from companies related to Pharmaceuticals & Medicine

Engineered Drug May Directly Fight Glioblastoma Tumors

Breakthrough Cancer Technology To Be Funded By The Crowd ...

Berubicin Breaches Blood-Brain Barrier to Attack Brain Tu...

Followers 5977

Companies
12

Events
0

Blog posts
1

Investor Groups
0

Press
32

Followers
5977